{
  "company_number": "08455348",
  "name": "Medevala Pharma Limited",
  "url": "/company/08455348",
  "status": "Active",
  "is_active": true,
  "company_type": "Private Limited Company",
  "incorporated_on": "2013-03-21",
  "dissolved_on": null,
  "sic_codes": [
    "47730"
  ],
  "registered_address": {
    "id": 769915,
    "url": "/address/769915",
    "line1": "24 SCOTTS ROAD",
    "line2": "",
    "post_town": "BROMLEY",
    "county": "",
    "country": "ENGLAND",
    "postcode": "BR1 3QD"
  },
  "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/08455348",
  "previous_names": [],
  "care_of": "",
  "po_box": "",
  "country_of_origin": "United Kingdom",
  "accounts": {
    "next_due": "2026-12-31",
    "last_made_up": "2025-03-31",
    "category": "TOTAL EXEMPTION FULL",
    "filings": [
      {
        "url": "/company/08455348/accounts/2025-03-31",
        "made_up_date": "2025-03-31",
        "period_start": "2025-03-31",
        "period_end": "2025-03-31",
        "entity_name": "Medevala Pharma Limited",
        "dormant": false,
        "average_employees": "1.00",
        "tangible_fixed_assets": "255948.00",
        "debtors": "6934.00",
        "cash_bank_in_hand": "1257.00",
        "current_assets": "8191.00",
        "creditors_due_within_one_year": "3666.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "4525.00",
        "total_assets_less_current_liabilities": null,
        "net_assets_liabilities": "260473.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": null,
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-December2025.zip"
      },
      {
        "url": "/company/08455348/accounts/2024-03-31",
        "made_up_date": "2024-03-31",
        "period_start": "2024-03-31",
        "period_end": "2024-03-31",
        "entity_name": "Medevala Pharma Limited",
        "dormant": false,
        "average_employees": "1.00",
        "tangible_fixed_assets": "255976.00",
        "debtors": "6933.00",
        "cash_bank_in_hand": "6397.00",
        "current_assets": "13330.00",
        "creditors_due_within_one_year": "2705.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "10625.00",
        "total_assets_less_current_liabilities": null,
        "net_assets_liabilities": "266601.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": null,
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-December2024.zip"
      },
      {
        "url": "/company/08455348/accounts/2023-03-31",
        "made_up_date": "2023-03-31",
        "period_start": "2023-03-31",
        "period_end": "2023-03-31",
        "entity_name": "Medevala Pharma Limited",
        "dormant": false,
        "average_employees": "0.00",
        "tangible_fixed_assets": "256012.00",
        "debtors": "6934.00",
        "cash_bank_in_hand": "5509.00",
        "current_assets": "12443.00",
        "creditors_due_within_one_year": "3474.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "8969.00",
        "total_assets_less_current_liabilities": null,
        "net_assets_liabilities": "264981.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": null,
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-December2023.zip"
      },
      {
        "url": "/company/08455348/accounts/2022-03-31",
        "made_up_date": "2022-03-31",
        "period_start": "2022-03-31",
        "period_end": "2022-03-31",
        "entity_name": "Medevala Pharma Limited",
        "dormant": false,
        "average_employees": "0.00",
        "tangible_fixed_assets": "256061.00",
        "debtors": "6934.00",
        "cash_bank_in_hand": "9358.00",
        "current_assets": "16292.00",
        "creditors_due_within_one_year": "6069.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "10223.00",
        "total_assets_less_current_liabilities": null,
        "net_assets_liabilities": "266284.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": null,
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-December2022.zip"
      },
      {
        "url": "/company/08455348/accounts/2021-03-31",
        "made_up_date": "2021-03-31",
        "period_start": "2021-03-31",
        "period_end": "2021-03-31",
        "entity_name": "Medevala Pharma Limited",
        "dormant": false,
        "average_employees": "2.00",
        "tangible_fixed_assets": "256126.00",
        "debtors": "6934.00",
        "cash_bank_in_hand": "19765.00",
        "current_assets": "26699.00",
        "creditors_due_within_one_year": "11944.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "14755.00",
        "total_assets_less_current_liabilities": null,
        "net_assets_liabilities": "270881.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": null,
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-December2021.zip"
      },
      {
        "url": "/company/08455348/accounts/2020-03-31",
        "made_up_date": "2020-03-31",
        "period_start": "2020-03-31",
        "period_end": "2020-03-31",
        "entity_name": "Medevala Pharma Limited",
        "dormant": false,
        "average_employees": "2.00",
        "tangible_fixed_assets": "256212.00",
        "debtors": "6934.00",
        "cash_bank_in_hand": "4878.00",
        "current_assets": "11812.00",
        "creditors_due_within_one_year": "2917.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "8895.00",
        "total_assets_less_current_liabilities": null,
        "net_assets_liabilities": "265107.00",
        "called_up_share_capital": "100.00",
        "profit_loss_account_reserve": "265007.00",
        "shareholder_funds": "265107.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-December2020.zip"
      },
      {
        "url": "/company/08455348/accounts/2019-03-31",
        "made_up_date": "2019-03-31",
        "period_start": "2019-03-31",
        "period_end": "2019-03-31",
        "entity_name": "Medevala Pharma Limited",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": "256429.00",
        "debtors": "6933.00",
        "cash_bank_in_hand": "180824.00",
        "current_assets": "187757.00",
        "creditors_due_within_one_year": "135769.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "51988.00",
        "total_assets_less_current_liabilities": "308417.00",
        "net_assets_liabilities": "308417.00",
        "called_up_share_capital": "100.00",
        "profit_loss_account_reserve": "308317.00",
        "shareholder_funds": "308417.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-December2019.zip"
      },
      {
        "url": "/company/08455348/accounts/2018-03-31",
        "made_up_date": "2018-03-31",
        "period_start": "2018-03-31",
        "period_end": "2018-03-31",
        "entity_name": "Medevala Pharma Limited",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": "267938.00",
        "debtors": "65512.00",
        "cash_bank_in_hand": "65486.00",
        "current_assets": "174343.00",
        "creditors_due_within_one_year": "130155.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "44188.00",
        "total_assets_less_current_liabilities": "312126.00",
        "net_assets_liabilities": "46512.00",
        "called_up_share_capital": "100.00",
        "profit_loss_account_reserve": "46412.00",
        "shareholder_funds": "46512.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-December2018.zip"
      },
      {
        "url": "/company/08455348/accounts/2017-03-31",
        "made_up_date": "2017-03-31",
        "period_start": "2017-03-31",
        "period_end": "2017-03-31",
        "entity_name": "Medevala Pharma Limited",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": "330305.00",
        "debtors": "61770.00",
        "cash_bank_in_hand": "26832.00",
        "current_assets": "129818.00",
        "creditors_due_within_one_year": "130108.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-290.00",
        "total_assets_less_current_liabilities": "330015.00",
        "net_assets_liabilities": "32021.00",
        "called_up_share_capital": "100.00",
        "profit_loss_account_reserve": "31921.00",
        "shareholder_funds": "32021.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-December2017.zip"
      },
      {
        "url": "/company/08455348/accounts/2016-03-31",
        "made_up_date": "2016-03-31",
        "period_start": "2016-03-31",
        "period_end": "2016-03-31",
        "entity_name": "Medevala Pharma Limited",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": "390278.00",
        "debtors": "30124.00",
        "cash_bank_in_hand": "48564.00",
        "current_assets": "114222.00",
        "creditors_due_within_one_year": "173604.00",
        "creditors_due_after_one_year": "327644.00",
        "net_current_assets_liabilities": "-59382.00",
        "total_assets_less_current_liabilities": "330896.00",
        "net_assets_liabilities": "3252.00",
        "called_up_share_capital": "100.00",
        "profit_loss_account_reserve": "3152.00",
        "shareholder_funds": "3252.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-September2016.zip"
      },
      {
        "url": "/company/08455348/accounts/2015-03-31",
        "made_up_date": "2015-03-31",
        "period_start": "2015-03-31",
        "period_end": "2015-03-31",
        "entity_name": "Medevala Pharma Limited",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": "451866.00",
        "debtors": "45661.00",
        "cash_bank_in_hand": "37249.00",
        "current_assets": "118973.00",
        "creditors_due_within_one_year": "191276.00",
        "creditors_due_after_one_year": "359203.00",
        "net_current_assets_liabilities": "-72303.00",
        "total_assets_less_current_liabilities": "379563.00",
        "net_assets_liabilities": "20360.00",
        "called_up_share_capital": "100.00",
        "profit_loss_account_reserve": "20260.00",
        "shareholder_funds": "20360.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-November2015.zip"
      }
    ],
    "pdf_only_filings": [],
    "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/08455348/filing-history"
  },
  "confirmation_statement": {
    "next_due": "2027-03-28",
    "last_made_up": "2026-03-14"
  },
  "officers": [],
  "psc": [
    {
      "name": "Mrs Laurie Thompson",
      "kind": "individual-person-with-significant-control",
      "person_url": "/person/2808808",
      "controlling_company_url": null,
      "natures_of_control": [
        "ownership-of-shares-25-to-50-percent",
        "voting-rights-25-to-50-percent",
        "right-to-appoint-and-remove-directors"
      ],
      "notified_on": "2016-04-06",
      "ceased_on": null,
      "nationality": "British",
      "country_of_residence": "England",
      "source": "snapshot"
    },
    {
      "name": "Mr Mark Robert Thompson",
      "kind": "individual-person-with-significant-control",
      "person_url": "/person/3150086",
      "controlling_company_url": null,
      "natures_of_control": [
        "ownership-of-shares-50-to-75-percent",
        "voting-rights-50-to-75-percent",
        "right-to-appoint-and-remove-directors"
      ],
      "notified_on": "2016-04-06",
      "ceased_on": null,
      "nationality": "British",
      "country_of_residence": "England",
      "source": "snapshot"
    }
  ],
  "external_links": [],
  "provenance": {
    "source": "snapshot",
    "first_seen_at": "2026-07-05T12:35:35.811816+00:00",
    "last_seen_snapshot": "2026-07-01",
    "retrieved_at": "2026-07-26T04:50:31.692265+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House."
}